Log in Book a Demo

US Pharma & Biotech Pharmacology - PPC Market Share Analysis March 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pharmacology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pharmacology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
ro.co 17.6
goodlifemeds.com 13.84
directhealthshop.com 11.79
redboxrx.com 9.83
aminousa.com 3.77
agelessrx.com 3.46
ivyrx.com 3.27
nurx.com 2.91
lemonaidhealth.com 2.44
reflexmd.com 1.51
others 29.58

Copyright © Adthena. All rights reserved.

In the pharmaceuticals PPC landscape, ‘ro.co’ leads with 17.6% click share, followed by ‘goodlifemeds.com’ at 13.84%. ‘Others’ collectively hold a significant 29.58%, highlighting diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pharmacology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date goodlifemeds.com ro.co nurx.com reflexmd.com lemonaidhealth.com ivyrx.com agelessrx.com directhealthshop.com mdexam.com redboxrx.com
2025/03/01 15.11% 31.7% 1.9% 0% 2.67% 3.37% 4.85% 0.87% 2% 0.09%
2025/03/02 13.88% 26.97% 2.67% 1.34% 2.89% 5.08% 3.26% 0.84% 2.65% 0.08%
2025/03/03 13.95% 28.5% 2.19% 1.57% 3.42% 5.6% 4.22% 1.39% 2.91% 4.15%
2025/03/04 15.59% 25.58% 2.71% 1.53% 2.45% 2.07% 3.09% 2.46% 4.89% 13.76%
2025/03/05 25.24% 29.09% 4.52% 2.11% 5.42% 4.17% 2.58% 3.61% 0.4% 6.85%
2025/03/06 20.26% 27.57% 4.03% 1.42% 2.23% 3.27% 3.35% 1.87% 0.71% 16.07%
2025/03/07 16.87% 34.84% 1.75% 1.62% 1.73% 1.41% 3.31% 1.45% 5.05% 7.95%
2025/03/08 13.5% 24.13% 2.83% 0% 0.8% 4.31% 2.46% 2.53% 0.22% 24.33%
2025/03/09 20.64% 21.4% 2.9% 1.11% 2.46% 3.82% 3.46% 4.12% 2.58% 18.25%
2025/03/10 19.1% 23.64% 2.2% 1.83% 2.9% 3.22% 1.47% 4.47% 2.05% 22.44%
2025/03/11 16.23% 27.66% 2.51% 3.6% 4.8% 3.25% 2.4% 2.45% 0.02% 24.19%
2025/03/12 22.93% 24.78% 2.76% 1.43% 7.87% 2.55% 2.42% 1.55% 0.43% 20.89%
2025/03/13 20.73% 25.13% 3.3% 1.9% 7.01% 2.17% 2.37% 3.61% 0.19% 19.57%
2025/03/14 23.4% 25.19% 3.05% 1.61% 9.02% 3.52% 2.5% 3.29% 0.47% 11.36%
2025/03/15 23.28% 26.76% 3.54% 0% 8.39% 3.72% 4.52% 2.65% 0.35% 11.39%
2025/03/16 18.35% 22.31% 2.64% 0.5% 8.08% 4.63% 4.46% 2.61% 0.86% 22.3%
2025/03/17 21.58% 20.21% 2.72% 1.96% 8.86% 4.04% 3.01% 2.74% 0.35% 18.18%
2025/03/18 28.13% 22.59% 3.43% 1.2% 2.6% 3.64% 2.73% 3.01% 0.37% 17.15%
2025/03/19 26.74% 19.66% 3.32% 3.16% 0.02% 3.84% 3.52% 4.4% 0.32% 17.94%
2025/03/20 18.52% 13.57% 4.46% 4.02% 0.08% 5.18% 4.82% 3.63% 0.21% 22.67%
2025/03/21 16.62% 13.44% 5.69% 2.35% 0.04% 4.53% 3.41% 4.08% 0.2% 27.53%
2025/03/22 14.4% 17.65% 4.49% 0% 0.01% 3.51% 7.95% 4.01% 0.28% 26.16%
2025/03/23 16.43% 15.23% 5.33% 0.36% 0.04% 5.26% 9.09% 4.24% 0.32% 23.31%
2025/03/24 18.21% 13.39% 4.96% 3.02% 0.01% 6.09% 5.47% 4.12% 3.17% 20.41%
2025/03/25 19.58% 15.53% 4.69% 1.64% 4.48% 2.34% 5.46% 7.02% 0.91% 19.72%
2025/03/26 20.67% 11.84% 6.53% 1.66% 7.08% 5.72% 7.85% 2.73% 1.88% 13.13%
2025/03/27 33.1% 17.6% 5.37% 0.7% 4.18% 3.74% 3.87% 3.86% 1.86% 4.56%
2025/03/28 33.99% 17.47% 5.27% 2.3% 4.07% 2.24% 2.64% 7.05% 1.13% 0.03%
2025/03/29 35.17% 15.35% 6.48% 0% 4.36% 3.9% 10.02% 2.37% 0.18% 0.01%
2025/03/30 33.22% 14.76% 6.37% 2.78% 5.5% 4.86% 4.09% 1.98% 0.37% 0.33%
2025/03/31 31.1% 13.78% 7.11% 6.71% 6.3% 5.75% 5.51% 4.65% 0.41% 0.02%

Copyright © Adthena. All rights reserved.

Goodlifemeds.com saw a steady rise, peaking at 35.17% on March 29. Ro.co’s share declined, ending at 13.78%. Nurx.com gradually increased, finishing at 7.11%. Reflexmd.com fluctuated, closing at 6.71%. Lemonaidhealth.com rebounded to 6.3%. Ivyrx.com ended at 5.75%. Agelessrx.com peaked at 10.02% on March 29. Directhealthshop.com saw a rise, closing at 4.65%. Mdexam.com remained low, ending at 0.41%. Redboxrx.com dropped significantly, finishing at 0.02%.

Market Exposure

Competitor Count for US Pharma & Biotech Pharmacology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/03/01 460
2025/03/02 469
2025/03/03 460
2025/03/04 438
2025/03/05 428
2025/03/06 437
2025/03/07 466
2025/03/08 458
2025/03/09 370
2025/03/10 377
2025/03/11 344
2025/03/12 337
2025/03/13 339
2025/03/14 361
2025/03/15 299
2025/03/16 302
2025/03/17 293
2025/03/18 282
2025/03/19 296
2025/03/20 303
2025/03/21 292
2025/03/22 311
2025/03/23 282
2025/03/24 271
2025/03/25 278
2025/03/26 299
2025/03/27 297
2025/03/28 293
2025/03/29 289
2025/03/30 285
2025/03/31 278

Copyright © Adthena. All rights reserved.

March began with 460 advertisers, peaking at 469, then steadily declined, ending at 278.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pharmacology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
directhealthshop.com 3.85%
agelessrx.com 1.79%
nurx.com 1.47%
goodlifemeds.com 1.46%
humnutrition.com 0.88%
kiyalongevity.com -0.54%
mdexam.com -0.76%
lemonaidhealth.com -1.53%
redboxrx.com -2.86%
ro.co -7.78%

Copyright © Adthena. All rights reserved.

Directhealthshop.com surged with a 3.85% click share increase, while ro.co faced a significant 7.78% decline.

Campaign Efficiency

US Pharma & Biotech Pharmacology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date goodlifemeds.com ro.co directhealthshop.com nurx.com agelessrx.com lemonaidhealth.com ivyrx.com pharmagradepeptides.is peptideworldwide.com redboxrx.com
2025/03/01 11.84% 27.32% 1.88% 2.03% 4.33% 2.42% 3.51% 2.41% 2.01% 1.71%
2025/03/02 11.1% 22.07% 1.89% 3.4% 3.1% 2.41% 4.83% 2.36% 1.42% 0.08%
2025/03/03 11.18% 23.97% 3.32% 3.02% 4.18% 2.75% 4.58% 2.35% 0.83% 4.23%
2025/03/04 11.81% 21.59% 5.44% 3.13% 2.8% 1.8% 1.82% 2.27% 2.27% 11.5%
2025/03/05 17.44% 20.97% 6.56% 4.99% 2.33% 3.9% 3.38% 2.3% 2.95% 6%
2025/03/06 14.52% 22.66% 3.45% 4.33% 2.87% 1.54% 2.92% 2.36% 2.2% 12.41%
2025/03/07 12.8% 29.44% 2.95% 1.71% 2.91% 1.19% 1.22% 1.48% 0.66% 6.8%
2025/03/08 10.06% 19.55% 5.11% 2.78% 2.12% 0.57% 3.77% 2.17% 1.08% 17.62%
2025/03/09 14.58% 17.21% 7.47% 2.49% 3.19% 1.54% 3.5% 2.61% 1.91% 15.12%
2025/03/10 13.62% 18.13% 8.78% 1.97% 1.27% 2.26% 2.63% 1% 2.99% 16.64%
2025/03/11 12.25% 22.27% 5.23% 2.4% 2.41% 3.75% 3.08% 0.58% 2.52% 18.92%
2025/03/12 17.79% 20.82% 3.61% 2.92% 2.42% 6.12% 2.3% 2.34% 2.52% 16.28%
2025/03/13 15.22% 20.16% 7.84% 3.18% 2.12% 5.04% 1.92% 2.43% 2.61% 14.64%
2025/03/14 16.38% 19.16% 6.7% 2.75% 2.27% 7.06% 3.11% 1.94% 1.94% 9.92%
2025/03/15 17.18% 21.39% 6.07% 3.58% 3.86% 6.51% 3.29% 3.04% 1.4% 10.74%
2025/03/16 13.79% 17.75% 5.79% 2.52% 4.4% 6.93% 4.43% 1.81% 2.17% 15.73%
2025/03/17 16.47% 16.34% 5.34% 3.02% 2.55% 6.43% 3.6% 0.79% 1.78% 13.71%
2025/03/18 19.19% 17.23% 5.74% 3.61% 2.1% 1.96% 2.96% 3.22% 3.45% 14.69%
2025/03/19 17.58% 14.78% 7.9% 3.74% 2.84% 0.02% 2.97% 4.26% 2.43% 13.08%
2025/03/20 11.63% 10.34% 6.84% 4.66% 3.66% 0.11% 4.04% 3.42% 3.42% 17.45%
2025/03/21 9.91% 10.7% 7.37% 5.51% 2.63% 0.07% 3.42% 1.7% 3.97% 17.17%
2025/03/22 9.15% 12.32% 6.94% 3.78% 6.24% 0.02% 2.83% 3.27% 2.86% 17.3%
2025/03/23 10.48% 11.34% 7.7% 5.29% 7.68% 0.05% 4.3% 1.87% 5.6% 14.74%
2025/03/24 11.27% 9.67% 8.05% 4.69% 4.25% 0.01% 5.12% 3.45% 3.74% 14.48%
2025/03/25 12.54% 12.13% 13.1% 4.51% 3.8% 3.23% 2.07% 4.37% 2.62% 14.11%
2025/03/26 13.88% 9.65% 5.03% 6.48% 5.98% 5.17% 4.74% 3.55% 3.26% 11.3%
2025/03/27 22% 13.49% 7.46% 5.72% 3.18% 3.65% 2.65% 3.32% 3.87% 3.91%
2025/03/28 21.09% 12.74% 11.77% 5.54% 2.13% 2.36% 1.72% 4.9% 2.29% 0.05%
2025/03/29 21.87% 11.36% 4.03% 5.43% 8.78% 2.64% 2.68% 4.03% 3.78% 0%
2025/03/30 21.38% 10.61% 3.73% 6.03% 3.28% 3.33% 3.51% 3.73% 2.66% 0.15%
2025/03/31 19.6% 9.46% 8.26% 6.72% 4.45% 4.34% 4.25% 3.1% 2.84% 0.04%

Copyright © Adthena. All rights reserved.

In March 2025, GoodLifeMeds saw a fluctuating impression share, peaking at 22.00% on March 27. Ro.co started strong but declined, ending at 9.46%. DirectHealthShop and Nurx showed moderate growth, while RedBoxRx’s share plummeted to near zero by month’s end.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pharmacology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    10 Best Tirzepatide Online - Best & Worst Picks of 2025 https://www.best-weightloss-meds.com/

    Mark March As The Month Your Transformation Begins - Lose Weight Easily!

  2. 2
    $299 a month https://www.fellahealth.com

    Fella GLP-1 - Don't Pay $1k/mo — Answer A Few Simple Questions And Find The Right Treatment For You. See Your GLP-1 Treatment...

  3. 3
    Fast Overnight Shipping https://intake.mdexam.com

    No Hidden Fees — Guaranteed results - Affordable, FDA-approved weight loss backed by a 180-day...

  4. 4
    Ozempic®, Prescribed Online - $45 to Start Ozempic https://www.ro.co

    See safety info, incl box warning. Just $45 To Get Started today. 1:1 health coaching from dedicated...

  5. 5
    No Insurance Needed - Tirzepatide Rx Online - Tirzepatide Prescription https://www.sesamecare.com

    Program Includes GLP-1 Medication, Video Consults, Unlimited Messaging, Lab Panels & More. Providers You Can Choose, Results You Can See. Learn Why Sesame Is A Step Above The Rest. Services: Primary Care, Weight Loss, Urgent Care, Dermatology.

Copyright © Adthena. All rights reserved.

In the competitive landscape of weight loss medications, five advertisers stand out with unique propositions. Best-weightloss-meds.com entices with transformation promises, while Fella Health offers affordability at $299/month. Mdexam.com highlights fast shipping and no hidden fees. Ro.co provides Ozempic® at $45 with personalized coaching. Sesamecare.com emphasizes comprehensive care without insurance.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.